149 related articles for article (PubMed ID: 22177608)
1. [French general practitioners' perceptions and use of neuraminidase inhibitors during the pandemic A(H1N1)2009 influenza].
Barthe J; Noyelle C; Partouche H
Sante Publique; 2011; 23(4):305-15. PubMed ID: 22177608
[TBL] [Abstract][Full Text] [Related]
2. Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public?
Schwarzinger M; Verger P; Guerville MA; Aubry C; Rolland S; Obadia Y; Moatti JP
Vaccine; 2010 Mar; 28(15):2743-8. PubMed ID: 20117271
[TBL] [Abstract][Full Text] [Related]
3. Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns.
Flicoteaux R; Pulcini C; Carrieri P; Schwarzinger M; Leport C; Verger P
Vaccine; 2014 Apr; 32(20):2281-7. PubMed ID: 24631097
[TBL] [Abstract][Full Text] [Related]
4. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
[TBL] [Abstract][Full Text] [Related]
5. High vaccination rates for seasonal and pandemic (A/H1N1) influenza among healthcare workers in Dutch general practice.
Opstelten W; van Essen GA; Heijnen ML; Ballieux MJ; Goudswaard AN
Vaccine; 2010 Aug; 28(38):6164-8. PubMed ID: 20659516
[TBL] [Abstract][Full Text] [Related]
6. [Seasonal and pandemic A (H1N1) 2009 influenza vaccination coverage among health-care workers in a French university hospital].
Boyeau C; Tanguy M; Pean S; Delhumeau A; Fanello S
Sante Publique; 2011; 23(1):19-29. PubMed ID: 21786736
[TBL] [Abstract][Full Text] [Related]
7. [Impact of the A influenza pandemic on anti-seasonal influenza vaccination of French general practitioners: A cohort follow-up 2007-2010].
Hurtaud A; Songis PH; Di Patrizio P; Boivin JM
Rev Epidemiol Sante Publique; 2014 Jun; 62(3):191-4. PubMed ID: 24840149
[TBL] [Abstract][Full Text] [Related]
8. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
Puzelli S; Facchini M; Di Martino A; Fabiani C; Lackenby A; Zambon M; Donatelli I
Antiviral Res; 2011 Jun; 90(3):205-12. PubMed ID: 21514326
[TBL] [Abstract][Full Text] [Related]
10. Cross-sectional survey: risk-averse French general practitioners are more favorable toward influenza vaccination.
Massin S; Ventelou B; Nebout A; Verger P; Pulcini C
Vaccine; 2015 Jan; 33(5):610-4. PubMed ID: 25545596
[TBL] [Abstract][Full Text] [Related]
11. Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase.
Torun SD; Torun F
Vaccine; 2010 Aug; 28(35):5703-10. PubMed ID: 20600497
[TBL] [Abstract][Full Text] [Related]
12. Pandemic influenza vaccines and neuraminidase inhibitors: efficacy and side effects.
Bijl D
Int J Risk Saf Med; 2011; 23(2):65-71. PubMed ID: 21673413
[TBL] [Abstract][Full Text] [Related]
13. Pandemic influenza (A/H1N1) vaccine uptake among French private general practitioners: a cross sectional study in 2010.
Verger P; Flicoteaux R; Schwarzinger M; Sagaon-Teyssier L; Peretti-Watel P; Launay O; Sebbah R; Moatti JP
PLoS One; 2012; 7(8):e41837. PubMed ID: 22879896
[TBL] [Abstract][Full Text] [Related]
14. [A survey about determinants of 2009 pandemic influenza A(H1N1) vaccination among French general practionners patients. Motivac study].
Partouche H; Benainous O; Barthe J; Pierret J; Rigal L; Michaloux M; Gilberg S
Rev Prat; 2011 Dec; 61(10):1411-7. PubMed ID: 22288355
[TBL] [Abstract][Full Text] [Related]
15. Use of neuraminidase inhibitors in primary health care during pandemic and seasonal influenza between 2009 and 2013.
Blanchon T; Geffrier F; Turbelin C; Daviaud I; Laouénan C; Duval X; Lambert B; Hanslik T; Mosnier A; Leport C
Antivir Ther; 2015; 20(7):753-61. PubMed ID: 25687219
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients.
Cotte L; Voirin N; Richard C; Brochier C; Schlienger I; Lack P; Lina B; Vanhems P; Zoulim F
Vaccine; 2011 Aug; 29(34):5638-44. PubMed ID: 21699948
[TBL] [Abstract][Full Text] [Related]
17. Influenza: epidemiology, clinical features, therapy, and prevention.
Clark NM; Lynch JP
Semin Respir Crit Care Med; 2011 Aug; 32(4):373-92. PubMed ID: 21858743
[TBL] [Abstract][Full Text] [Related]
18. [Status of and factors influencing vaccination against the pandemic (H1N1) 2009 virus among university students from the fields of nursing and allied health].
Kim OS
J Korean Acad Nurs; 2011 Jun; 41(3):403-10. PubMed ID: 21804349
[TBL] [Abstract][Full Text] [Related]
19. Community knowledge, risk perception, and preparedness for the 2009 influenza A/H1N1 pandemic.
Jehn M; Kim Y; Bradley B; Lant T
J Public Health Manag Pract; 2011; 17(5):431-8. PubMed ID: 21788781
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1241-5. PubMed ID: 19910912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
